Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors-Reference-Cited by-同舟云学术

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

Published:1988-06 Issue:2 Volume:94 Page:397-412
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Butler A.,Hill J.M.,Ireland S.J.,Jordan C.C.,Tyers M.B.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1988.tb11542.x/fullpdf

Reference42 articles.

1. GR38032F, a novel S-HT3 receptor antagonist, can abolish emesis induced by cyclophosphamide or radiation in the ferret;ANDREWS;Br. J. Pharmacol,1987

2. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature;APPERLEY;Br. J. Pharmacol,1980

3. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta;APPERLEY;Br. J. Pharmacol,1976

4. Prenalterol is an agonist at β2 as well as at β1-adrenoceptors;APPERLEY;Eur. J. Pharmacol,1982

5. Some quantitative uses of drug antagonists;ARUNLAKSHANA;Br. J. Pharmacol. Chemother,1959

Cited by 385 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Targeting of Serotonin 5-HT1a and 5-HT3 Receptors Attenuates Acute and Long-Term Hypersensitivity Associated With Neonatal Procedural Pain;Frontiers in Pain Research;2022-04-27

2. Evidence for 5‐HT 1A receptor‐mediated antiallodynic and antihyperalgesic effects of apigenin in mice suffering from mononeuropathy;British Journal of Pharmacology;2021-06-22

3. Enantioseparation of ondansetron by countercurrent chromatography using sulfobutyl ether‐β‐cyclodextrin as chiral selector;Journal of Separation Science;2021-01-18

4. Serotonergically dependent antihyperalgesic and antiallodynic effects of isoliquiritin in a mouse model of neuropathic pain;European Journal of Pharmacology;2020-08

5. Isorhynchophylline Exerts Antinociceptive Effects on Behavioral Hyperalgesia and Allodynia in a Mouse Model of Neuropathic Pain: Evidence of a 5-HT1A Receptor-Mediated Mechanism;Frontiers in Pharmacology;2020-03-18